David Russel
University of East Anglia, Norwich, UK
Functionalised gold nanoparticles for the measurement of intracellular nitric oxide and for targeted photodynamic cancer therapy
Jordi Muntané Relat
Instituto de Biomedicina de Sevilla, ES
Integration of oxidative and nitrosative stress in the overall cell death signaling induced by Sorafenib in hepatoma cells
S. Perwez Hussain
National Cancer Institute, Bethesda, USA
Nitric Oxide as an Enhancer of Pancreatic Cancer Progression: A Potential Therapeutic Opportunity
Albert W. Girotti
Medical College of Wisconsin, USA
Role of endogenous nitric oxide in hyper-aggressiveness of tumour cells that survive a photodynamic therapy challenge
Khosrow Kashfi
City University of New York, USA
Molecular targets of NOSH-aspirin in a xenograft mouse model of ER(-) breast cancer
Salvatore Sortino
University of Catania, Italy
Nitric Oxide Photodelivering Nanoconstructs
David A. Wink
National Cancer Institute, Bethesda, USA
The synergistic action of NOS2 and COX2 in progression of ER(-) Breast Cancer
Vasily A. Yakovlev
Virginia Commonwealth University, Richmond, USA
Nitric oxide in maintaining of genomic instability and synthetic lethality - two sides of the same coin
Stéphanie Plenchette-Colas
EPHE-University of Burgundy, Dijon (FR)
S-nitrosylation of cIAP1 switches cancer cell fate from TNFα/TNFR1-mediated cell survival to death
Georg Bauer
University Medical Center, Freiburg, DE
Nitric oxide acts at multiple sites during selective apoptosis induction in tumor cells
Timothy R. Billiar
University of Pittsburgh, USA
iNOS regulates the phenotype of liver cancer stem cells
Giuseppe Filomeni
Danish Cancer Society Research Center, Copenhagen, DK
GSNOR and mitochondria crosstalk: implications in cancer therapy and ageing